Market Cap 31.73B
Revenue (ttm) 4.03B
Net Income (ttm) 576.20M
EPS (ttm) N/A
PE Ratio 47.59
Forward PE 39.53
Profit Margin 14.29%
Debt to Equity Ratio 0.48
Volume 3,470,200
Avg Vol 3,629,376
Day's Range N/A - N/A
Shares Out 392.16M
Stochastic %K 93%
Beta 1.43
Analysts Strong Sell
Price Target $102.60

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized thir...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 200 0200
Address:
6340 Sequence Drive, San Diego, United States
ckjamesst
ckjamesst Aug. 21 at 4:55 AM
$DXCM hint
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 4:54 AM
$DXCM good luck everyone I know where this is going will avg my option
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 2:41 AM
$DXCM spinning Top candle
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 9:07 PM
$DXCM wow what a buy
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 6:34 PM
$DXCM 5y macd double top diverge
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 5:55 PM
$DXCM do you see what I see lol
1 · Reply
ckjamesst
ckjamesst Aug. 20 at 4:33 PM
$DXCM quite and dangerous is a bubble: get out while you can
0 · Reply
biostock
biostock Aug. 20 at 4:11 PM
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 3:50 PM
$DXCM accumulation manipulation and distribution
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 3:24 PM
$DXCM you should see the chart and say this is goona go down. I truly believe this will go lower 70s
0 · Reply
Latest News on DXCM
DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 8:58 PM EDT - 22 days ago

DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript


Dexcom beats estimates for quarterly results, names new CEO

Jul 30, 2025, 5:23 PM EDT - 22 days ago

Dexcom beats estimates for quarterly results, names new CEO


DexCom: Delivering Consistent Growth

Jul 21, 2025, 11:26 AM EDT - 4 weeks ago

DexCom: Delivering Consistent Growth


The Best Growth Stocks to Buy

Jul 8, 2025, 8:12 AM EDT - 6 weeks ago

The Best Growth Stocks to Buy

ALGM AMZN AVGO BURL CTRE DAR GE


DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure

May 9, 2025, 11:00 AM EDT - 3 months ago

DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure


DexCom: Growth Is Reaccelerating But Don't Ignore The Risks

May 5, 2025, 4:34 AM EDT - 3 months ago

DexCom: Growth Is Reaccelerating But Don't Ignore The Risks


DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript

May 1, 2025, 9:04 PM EDT - 4 months ago

DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript


DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance

Apr 10, 2025, 11:34 AM EDT - 4 months ago

DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance


Dexcom Appoints Jon Coleman as Chief Commercial Officer

Mar 25, 2025, 4:05 PM EDT - 5 months ago

Dexcom Appoints Jon Coleman as Chief Commercial Officer


Dexcom Appoints Renée Galá to Board of Directors

Mar 10, 2025, 8:30 AM EDT - 5 months ago

Dexcom Appoints Renée Galá to Board of Directors


DexCom Gets FDA Warning Letter After Inspections of Facilities

Mar 7, 2025, 5:33 PM EST - 5 months ago

DexCom Gets FDA Warning Letter After Inspections of Facilities


Dexcom Announces Upcoming Conference Presentation

Feb 27, 2025, 8:30 AM EST - 6 months ago

Dexcom Announces Upcoming Conference Presentation


Quality Key in Volatile Market, NFLX & DXCM Value Plays

Feb 21, 2025, 3:48 PM EST - 6 months ago

Quality Key in Volatile Market, NFLX & DXCM Value Plays

NFLX


DexCom Analysts Increase Their Forecasts After Q4 Earnings

Feb 14, 2025, 9:22 AM EST - 6 months ago

DexCom Analysts Increase Their Forecasts After Q4 Earnings


DexCom, Inc. (DXCM) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 9:33 PM EST - 6 months ago

DexCom, Inc. (DXCM) Q4 2024 Earnings Call Transcript


ckjamesst
ckjamesst Aug. 21 at 4:55 AM
$DXCM hint
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 4:54 AM
$DXCM good luck everyone I know where this is going will avg my option
0 · Reply
ckjamesst
ckjamesst Aug. 21 at 2:41 AM
$DXCM spinning Top candle
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 9:07 PM
$DXCM wow what a buy
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 6:34 PM
$DXCM 5y macd double top diverge
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 5:55 PM
$DXCM do you see what I see lol
1 · Reply
ckjamesst
ckjamesst Aug. 20 at 4:33 PM
$DXCM quite and dangerous is a bubble: get out while you can
0 · Reply
biostock
biostock Aug. 20 at 4:11 PM
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 3:50 PM
$DXCM accumulation manipulation and distribution
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 3:24 PM
$DXCM you should see the chart and say this is goona go down. I truly believe this will go lower 70s
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 3:22 PM
$DXCM delivers solid 15% revenue growth — but is it enough? 📈 With a strong boost from U.S. and international markets, $DXCM raised its full-year revenue guidance, spotlighting the expanding type 2 non-insulin segment as a key growth driver. Yet, margin pressures and regulatory uncertainties loom, complicating the risk-reward balance. Discover if $DXCM's momentum can overcome near-term challenges 👉 https://www.zacks.com/stock/news/2740344/dexcom-expands-access-and-innovation-while-balancing-headwinds?cid=sm-stocktwits-2-2740344-body-8584&ADID=SYND_STOCKTWITS_TWEET_2_2740344_BODY_8584
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 2:22 PM
$DXCM — growth story or margin trap? Type 2 access, Stelo adoption, and fresh sensor launches are fueling upside… but margin pressures, competition, and a leadership transition can’t be ignored. Full breakdown here 👉 https://www.zacks.com/stock/news/2740344/dexcom-expands-access-and-innovation-while-balancing-headwinds?cid=sm-stocktwits-2-2740344-teaser-8582&ADID=SYND_STOCKTWITS_TWEET_2_2740344_TEASER_8582
0 · Reply
ckjamesst
ckjamesst Aug. 20 at 12:12 PM
$DXCM sell the event and buy the crash event
0 · Reply
NorthstarT1D
NorthstarT1D Aug. 20 at 6:47 AM
$DXCM https://www.cnbc.com/2025/08/20/fda-approves-signos-glucose-monitoring-for-weight-loss.html Uses Dexcom sensors.
0 · Reply
Cladkeeper
Cladkeeper Aug. 20 at 3:04 AM
$DXCM Don’t know why many of you are shitting on this. There’s research co’s that have a buy on it and there’s 28 analysts who have a buy signal
0 · Reply
ckjamesst
ckjamesst Aug. 19 at 6:41 PM
$DXCM hidden divergence play tomorrow :)
0 · Reply
ckjamesst
ckjamesst Aug. 19 at 6:08 PM
$DXCM play long boys :)
0 · Reply
ckjamesst
ckjamesst Aug. 19 at 3:56 PM
$DXCM its been fking 2 weeks and we don’t know where we going wtf bro
0 · Reply
biostock
biostock Aug. 19 at 2:57 PM
$DXCM 102 Squeeze it boys. $SPY $QQQ
0 · Reply
MakeInflationGreatAgain
MakeInflationGreatAgain Aug. 18 at 11:25 PM
$TNDM $MDT $DXCM https://www.sciencealert.com/first-of-its-kind-cell-transplant-brings-a-cure-for-diabetes-closer
0 · Reply
ckjamesst
ckjamesst Aug. 18 at 9:43 PM
$DXCM new CEO sucks
0 · Reply
ckjamesst
ckjamesst Aug. 18 at 9:40 PM
$DXCM this needs to go down soon…
0 · Reply